跳至主要内容
临床试验/IRCT20220610055128N1
IRCT20220610055128N1尚未招募3 期

Evaluation and comparison of bleeding and Activated Clotting Time (ACT) after coronary artery bypass grafting in protamine-heparin injection 1: 1 and protamine-heparin 0.5: 1

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Omitting anti-coagulation drugs at least one week prior to surgery
  • Patient should be a candidate for coronary artery bypass grafting
  • Informed consent to participate in the study
  • CPB duration less than 100 minutes

排除标准

  • Allergy and the risk of anaphylaxia shock
  • Coagulation abnormality
  • Bleeding and hemostasis dysfunctions due to non-medical causes
  • Patients dependent on dialysis and patients suffering from blood dyscrasia and known platelet dysfunction
  • Heparin re-administration
  • Need for emergency surgery
  • Patients with BMIs higher than 30
  • Under 28 degrees hypothermia
  • Dissent to participate in the study

研究者

相似试验